arrow
F

Frédéric Nikièma

institut de recherche en sciences de la sante
H指数:13
被引数:1,036

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

The anti-circumsporozoite antibody response to repeated, seasonal booster doses of the malaria vaccine RTS,S/AS01E
2025-02-060
OAAI
Safety and efficacy of repeat ivermectin mass drug administrations for malaria control (RIMDAMAL II): a phase 3, double-blind, placebo-controlled, cluster-randomised, parallel-group trial

重复伊维菌素大规模药物给药用于疟疾控制的 Safety and efficacy (安全性及有效性) (RIMDAMAL II):一项第3期、双盲、安慰剂对照、整群随机、平行组试验

2025-02-040
PRE
Seasonal vaccination with RTS,S/AS01E vaccine with or without seasonal malaria chemoprevention in children up to the age of 5 years in Burkina Faso and Mali: a double-blind, randomised, controlled, phase 3 trial
2024-01-0117
OAAI
The Anti-Circumsporozoite Antibody Response of Children to Seasonal Vaccination With the RTS,S/AS01E Malaria Vaccine

儿童对季节性接种RTS,S/AS01E疟疾疫苗的抗环子孢子抗体反应

2021-12-117
OAAI
Seasonal Malaria Vaccination with or without Seasonal Malaria Chemoprevention
2021-09-09123
OA
Persistent Submicroscopic Plasmodium falciparum Parasitemia 72 Hours after Treatment with Artemether-Lumefantrine Predicts 42-Day Treatment Failure in Mali and Burkina Faso
2021-07-167
OAAI
The Duration of Protection from Azithromycin Against Malaria, Acute Respiratory, Gastrointestinal, and Skin Infections When Given Alongside Seasonal Malaria Chemoprevention: Secondary Analyses of Data from a Clinical Trial in Hounde, Burkina Faso, and Bougouni, Mali
2021-01-089
OAAI
Evaluation of seasonal malaria chemoprevention in two areas of intense seasonal malaria transmission: Secondary analysis of a household-randomised, placebo-controlled trial in Hounde District, Burkina Faso and Bougouni District, Mali
2020-08-2122
OAAI
The duration of chemoprophylaxis against malaria after treatment with artesunate-amodiaquine and artemether-lumefantrine and the effects of pfmdr1 86Y and pfcrt 76T: a meta-analysis of individual patient data
2020-02-2528
OAAI
Pyronaridine-artesunate or dihydroartemisinin-piperaquine versus current first-line therapies for repeated treatment of uncomplicated malaria: a randomised, multicentre, open-label, longitudinal, controlled, phase 3b/4 trial

吡那啶-青蒿琥酯或双氢青蒿素-哌喹与目前的一线疗法用于重复治疗无并发症的疟疾: 一项随机,多中心,开放标签,纵向,对照,3b/4期试验

LANCET
IF88.5
2018-04-01102
OAAI
Safety and efficacy of re-treatments with pyronaridine-artesunate in African patients with malaria: a substudy of the WANECAM randomised trial
2016-02-0158
OAAI
Clinical determinants of early parasitological response to ACTs in African patients with uncomplicated falciparum malaria: a literature review and meta-analysis of individual patient data
2015-09-0760
OAAI
The effect of dosing strategies on the therapeutic efficacy of artesunate-amodiaquine for uncomplicated malaria: a meta-analysis of individual patient data

剂量策略对青蒿琥酯-阿莫迪喹治疗无并发症疟疾疗效的影响: 个体患者数据的荟萃分析

2015-03-3138
OAAI